CORESTEMCHEMON Inc. (KOSDAQ:166480)
South Korea · Delayed Price · Currency is KRW 3,250.00
+40.00 (1.25%)
At close: Apr 23, 2026
CORESTEMCHEMON Market Cap
CORESTEMCHEMON has a market cap or net worth of 141.95 billion as of April 24, 2026. Its market cap has increased by 84.12% in one year.
Market Cap
141.95B
Enterprise Value
172.71B
Revenue
20.16B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,250.00
Market Cap Chart
Since June 26, 2015, CORESTEMCHEMON's market cap has decreased from 653.85B to 141.95B, a decrease of -78.29%. That is a compound annual growth rate of -13.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 141.95B | 73.16% |
| Dec 30, 2025 | 81.98B | -13.27% |
| Dec 30, 2024 | 94.52B | -34.79% |
| Dec 28, 2023 | 144.95B | -43.25% |
| Dec 29, 2022 | 255.40B | -13.00% |
| Dec 30, 2021 | 293.58B | -19.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ISU Abxis | 201.81B |
| Prestige Biologics | 189.72B |
| Ensol Biosciences | 189.64B |
| QuadMedicine | 149.50B |
| BIO-FD&C | 125.65B |
| NovMetaPharma | 121.99B |
| Cell Biotech | 110.12B |
| KoBioLabs | 103.50B |